10 results
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary
myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
Myelodysplastic Syndrome ... old, ~10,000 new cases ... • Risks: infection ... #treatment #hematology ... #oncology
Treatment Schema for Standard-Risk Acute Lymphoblastic Leukemia
Induction: 
 • Vincristine, Steroid (dexamethasone), L-Asparaginase, Intrathecal (IT) methotrexate
Consolidation
Treatment Schema ... for Standard-Risk ... #timeline #oncology ... #pediatrics #peds ... #management
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
Algorithm Evaluate ... for causes of secondary ... , benefits and risks ... of medications ... #Algorithm #Management
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm
Lifestyle  Modifications (Diet and Exercise) -> Start
Diagnosis and Management ... Algorithm Lifestyle ... • Secondary Causes ... Endocrinopathies (Cushing Syndrome ... Rubella) • Medications
Hepatorenal Syndrome - Diagnosis and Management Summary
Who gets HRS?
 • Decompensated cirrhosis
 • Typically with existing
Hepatorenal Syndrome ... Diagnosis and Management ... present, higher risk ... a precipitant: Medications ... circulatory overload, CV ischemia
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
and petechiae Causes ... - Antithyroid medications ... aplastic anemia Treatment ... Aplastic #Anemia #oncology ... hematology #diagnosis #management
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Risk factors 3. ... Electrolyte abnormality, Medication ... the underlying cause ... • Treatment of ... #diagnosis #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... history of: a) Ischemic ... event, follow ACC algorithm ... Cataract Plan for Meds ... medical and surgical management
IDSA - Approach to Treating a Patient With Diabetic Foot Osteomyelitis
When to consider a trial of
of nonsurgical treatment ... 48–72 h if on treatment ... destruction has not caused ... Persistent sepsis syndrome ... #nonoperative #management
Management of Immune Checkpoint Inhibitor (ICI) Induced Cardiotoxicity
Problem - Immune checkpoint inhibitors (ICIs) are associated with
conditions including ischemia ... requiring intravenous medications ... other potential causes ... Cardiotoxicity #cardiology #oncology ... #management #treatment